Stock AVTR AVANTOR, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Avantor, Inc.

Equities

AVTR

US05352A1007

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 16:00:02 2024-05-03 EDT 		5-day change 1st Jan Change
24.72 USD +1.64% Intraday chart for Avantor, Inc. -3.30% +6.53%
04-29 RBC Capital Adjusts Price Target on Avantor to $30 From $29, Maintains Outperform Rating MT
04-29 Baird Trims Price Target on Avantor to $26 From $27, Maintains Outperform Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 10,377 16,280 25,682 14,219 15,442 16,520 - -
Enterprise Value (EV) 1 15,307 20,888 32,404 20,134 20,759 21,173 20,416 19,554
P/E ratio -21.6 x 313 x 49.6 x 20.9 x 48.6 x 35.8 x 25.6 x 21 x
Yield - - - - - - - -
Capitalization / Revenue 1.72 x 2.55 x 3.48 x 1.89 x 2.22 x 2.38 x 2.26 x 2.14 x
EV / Revenue 2.53 x 3.27 x 4.39 x 2.68 x 2.98 x 3.05 x 2.79 x 2.54 x
EV / EBITDA 14.8 x 18.3 x 22.2 x 12.8 x 15.9 x 17.2 x 14.6 x 12.8 x
EV / FCF 50.6 x 24.1 x 35.2 x 28.3 x 28.7 x 34 x 24.8 x 20.9 x
FCF Yield 1.98% 4.16% 2.84% 3.53% 3.49% 2.94% 4.03% 4.78%
Price to Book 4.23 x 6.11 x 6.22 x 2.95 x - 2.86 x 2.54 x 2.32 x
Nbr of stocks (in thousands) 571,735 578,339 609,453 674,204 676,386 679,266 - -
Reference price 2 18.15 28.15 42.14 21.09 22.83 24.32 24.32 24.32
Announcement Date 20-02-07 21-02-03 22-02-03 23-02-03 24-02-14 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,040 6,394 7,386 7,512 6,967 6,938 7,323 7,708
EBITDA 1 1,031 1,142 1,459 1,571 1,309 1,230 1,398 1,527
EBIT 1 944.6 1,054 1,370 1,484 1,214 1,125 1,285 1,395
Operating Margin 15.64% 16.48% 18.55% 19.75% 17.43% 16.22% 17.55% 18.1%
Earnings before Tax (EBT) 1 40.6 62.3 753 851.1 410.5 522.5 776.2 931.6
Net income 1 -335.1 52 508 662.3 321.1 427.9 622.4 732.8
Net margin -5.55% 0.81% 6.88% 8.82% 4.61% 6.17% 8.5% 9.51%
EPS 2 -0.8400 0.0900 0.8500 1.010 0.4700 0.6803 0.9508 1.160
Free Cash Flow 1 302.4 868.2 920.3 710.2 723.6 623.2 822.5 933.8
FCF margin 5.01% 13.58% 12.46% 9.45% 10.39% 8.98% 11.23% 12.11%
FCF Conversion (EBITDA) 29.33% 76.05% 63.09% 45.22% 55.27% 50.68% 58.83% 61.17%
FCF Conversion (Net income) - 1,669.62% 181.16% 107.23% 225.35% 145.63% 132.15% 127.44%
Dividend per Share 2 - - - - - - - -
Announcement Date 20-02-07 21-02-03 22-02-03 23-02-03 24-02-14 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,908 1,950 1,910 1,856 1,795 1,780 1,744 1,720 1,723 1,680 1,705 1,750 1,800 1,780 1,805
EBITDA 1 369.8 423.1 404.1 384 359.5 346.2 343 317.8 302.1 283 293.6 316 337.3 335.7 333.6
EBIT 1 346.1 400.8 382.2 363.2 337.3 319.8 319.3 295.2 276.5 258.4 266.7 289.3 310.3 307.1 306.5
Operating Margin 18.14% 20.55% 20.01% 19.56% 18.79% 17.96% 18.31% 17.16% 16.05% 15.38% 15.64% 16.53% 17.25% 17.26% 16.98%
Earnings before Tax (EBT) 1 140 241.8 226.3 208.3 174.7 155.8 -1.3 136.5 119.5 80.6 114.3 140.2 172.5 186.2 201.3
Net income 1 77.8 174.3 179.3 167 141.7 121.5 -7.3 108.4 98.5 60.4 97.55 119.2 141.2 144.2 156
Net margin 4.08% 8.94% 9.38% 9% 7.89% 6.82% -0.42% 6.3% 5.72% 3.6% 5.72% 6.81% 7.85% 8.1% 8.64%
EPS 2 0.1300 0.2800 0.2800 0.2500 0.2100 0.1800 -0.0100 0.1600 0.1500 0.0900 0.1638 0.1928 0.2199 0.2689 0.2801
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 22-02-03 22-04-28 22-07-28 22-10-28 23-02-03 23-04-28 23-07-28 23-10-27 24-02-14 24-04-26 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 4,930 4,607 6,722 5,915 5,317 4,654 3,896 3,035
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 4.781 x 4.036 x 4.608 x 3.766 x 4.062 x 3.785 x 2.787 x 1.988 x
Free Cash Flow 1 302 868 920 710 724 623 822 934
ROE (net income / shareholders' equity) 22.9% 22.4% 26.4% 21.1% 14.2% 12.2% 13% 13.3%
ROA (Net income/ Total Assets) 3.8% 5.85% 7.62% 6.98% 5.45% 6.27% 7.69% 7.59%
Assets 1 -8,828 889.6 6,664 9,483 5,894 6,824 8,095 9,659
Book Value Per Share 2 4.290 4.610 6.780 7.150 - 8.510 9.560 10.50
Cash Flow per Share 2 0.8800 1.590 1.590 1.240 1.280 1.290 1.450 1.840
Capex 1 51.6 61.6 111 133 146 148 154 153
Capex / Sales 0.85% 0.96% 1.5% 1.78% 2.1% 2.14% 2.1% 1.99%
Announcement Date 20-02-07 21-02-03 22-02-03 23-02-03 24-02-14 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Avantor, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
24.32 USD
Average target price
27.77 USD
Spread / Average Target
+14.17%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
AVANTOR, INC. Stock Avantor, Inc.
+6.53% 16.52B
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.79% 184B
MEDTRONIC PLC Stock Medtronic plc
-0.84% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.75% 69.44B
DEXCOM, INC. Stock DexCom, Inc.
+3.47% 50.37B
CENCORA, INC. Stock Cencora, Inc.
+9.04% 44.82B
HOYA CORPORATION Stock Hoya Corporation
+3.40% 41.53B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.66% 26.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.21% 26.73B
TERUMO CORPORATION Stock Terumo Corporation
+15.23% 25.71B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. AVTR Stock
  4. Financials Avantor, Inc.